Publicacións en colaboración con investigadores/as de Instituto Dante Pazzanese de Cardiologia (11)

2021

  1. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy

    Forensic Science International: Genetics, Vol. 52

2019

  1. Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology

    Global Heart, Vol. 14, Núm. 1, pp. 3-16.e1

  2. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths

    Forensic Science International: Genetics, Vol. 42, pp. 203-212

2017

  1. ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy

    Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474

  2. Quantification of bleeding during dental extraction in patients on dual antiplatelet therapy

    International Journal of Oral and Maxillofacial Surgery, Vol. 46, Núm. 9, pp. 1151-1157

2013

  1. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response

    Clinica Chimica Acta, Vol. 417, pp. 8-11

  2. Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome

    Clinica Chimica Acta, Vol. 421, pp. 184-190

  3. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients

    Clinica Chimica Acta, Vol. 425, pp. 9-17

2012

  1. Differentiation of African components of ancestry to stratify groups in a case-control study of a Brazilian urban population

    Genetic Testing and Molecular Biomarkers, Vol. 16, Núm. 6, pp. 524-530

  2. Increased clopidogrel response is associated with ABCC3 expression: A pilot study

    Clinica Chimica Acta, Vol. 413, Núm. 3-4, pp. 417-421

2011

  1. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388a>G variant is determinant of increased atorvastatin response

    International Journal of Molecular Sciences, Vol. 12, Núm. 9, pp. 5815-5827